- 101. apoplipoprotein AI
- [ ] (UMLS (CSP) C0872100) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 151. appetite
- [natural recurring desire for food. ( CSP )] (UMLS (CSP) C0003618) =Organism Function
|
- 102. apoptosis
- [(ap-o-TOE-sis) A normal series of events in a cell that leads to its death. ( NCI )] (UMLS (NCI) C0162638) =Cell Function ;
=cell death;
Cellular Biology | - 152. appetite disorder
- [ ] (UMLS (CSP) C0003621) =Mental or Behavioral Dysfunction
|
- 103. Apoptosis Antigen Ligand 1
- [FAS ligand is a TNF family, type II transmembrane protein expressed on many cell types and secreted from T-cells upon TCR ligation by MHC/peptide complexes residing on antigen presenting cells. FAS ligand triggers cell death by binding to the cell surface receptor FAS, another transmembrane protein member of the TNF receptor family. FAS ligand is expressed in activated splenocytes and thymocytes, consistent with its involvement in T-cell-mediated cytotoxicity, and in the liver, lung, ovary, and heart, where its function is unclear. (from OMIM 134638 and NCI) ( NCI )] (UMLS (NCI) C0253023) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 153. appetite regulation
- [Physiologic mechanisms which regulate or control the appetite and food intake. ( MSH )] (UMLS (CSP) C0003622) =Organism Function
|
- 104. Apoptosis Inducing Protein TRICK2A/2B
- [Receptor for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) ( NCI )] (UMLS (NCI) C0664123) =Amino Acid, Peptide, or Protein; Receptor ;
| - 154. appetite regulatory center
- [group of cells in the hypothalamus that when stimulated cause or suppress the sensation of hunger; the lateral hypothalamus contains the group of cells that when stimulated cause hunger sensation; the ventromedial hypothalamus contains the group of cells that when stimulated suppress the desire for food. ( CSP )] (UMLS (CSP) C0178484) =Body Location or Region =brain regulatory center;
|
- 105. Apoptosis Induction
- [Mechanisms involved in Induction of Apoptosis initiate biochemical processes, often enzymatic cascades, that promote programmed cell death. ( NCI )] (UMLS (NCI) C1326205) Induction of Apoptosis;
=Cell Function | - 155. APPL EXT FIX DEV-PATELLA
- [ ] (UMLS (ICD9CM) C0177387) =Therapeutic or Preventive Procedure
|
- 106. Apoptosis Inhibitor
- [Encoded by Apoptosis Inhibitor Genes, Apoptosis Inhibitor proteins impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332320) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 156. APPL EXT FIX-CHEST CAGE
- [ ] (UMLS (ICD9CM) C0177382) =Therapeutic or Preventive Procedure
|
- 107. Apoptosis Inhibitor 2
- [Encoded by BIRC3 Gene (IAP Family) Baculoviral IAP Repeat-Containing Protein 3 inhibits apoptosis by binding to TNF Receptor-associated factors TRAF1 and TRAF2, probably by interfering with activation of ICE-like proteases. BIRC3 inhibits apoptosis induced by serum deprivation but does not affect apoptosis resulting from exposure to menadione, a potent inducer of free radicals. The amino acid sequence predicts three baculovirus IAP repeat domains and a ring-type zinc finger domain while the Zn binding domain is involved in protein-protein interactions in caspase inhibition and spindle assembly. BIRC3 is present in many fetal and adult tissues and mainly expressed in adult skeletal muscle, thymus, testis, ovary, and pancreas, low or absent in brain and peripheral blood leukocytes. ( NCI )] (UMLS (NCI) C0763658) Baculoviral IAP Repeat-Containing Protein 3;
BIRC3;
Cellular Inhibitor of Apoptosis-2;
Human Inhibitor of Apoptosis Protein-1;
Mammalian IAP Homolog C;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 157. APPL EXT FIX-METACAR/CAR
- [ ] (UMLS (ICD9CM) C0177385) =Therapeutic or Preventive Procedure
|
- 108. Apoptosis Inhibitor 3
- [Encoded BIRC4 Gene (IAP Family), Baculoviral IAP Repeat-Containing Protein 4 inhibits apoptosis through binding to TNF Receptor-associated factors TRAF1 and TRAF2. Similar to BIRC2, BIRC4 inhibits apoptosis induced by menadione, a potent inducer of free radicals, and ICE. BIRC4 also specifically inhibits cell-death proteases, caspase-3 and caspase-7. A novel transcript homologous to BIRC4 is expressed solely in the testis. ( NCI )] (UMLS (NCI) C1173600) Baculoviral IAP Repeat-Containing Protein 4;
BIRC4;
IAP-Like Protein;
X-linked Inhibitor of Apoptosis =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 158. APPL EXT FIX-METATAR/TAR
- [ ] (UMLS (ICD9CM) C0177389) =Therapeutic or Preventive Procedure
|
- 109. Apoptosis Inhibitor Gene
- [Apoptosis Inhibitor Genes encode Apoptosis Inhibitor proteins, which impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332321) =Gene or Genome ;
| - 159. APPL EXT FIX-RADIUS/ULNA
- [ ] (UMLS (ICD9CM) C0177384) =Therapeutic or Preventive Procedure
|
- 110. Apoptosis Promoter
- [Encoded by Apoptosis Promoter Genes, Apoptosis Promoter proteins promote the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332322) Inducer of Apoptosis =Amino Acid, Peptide, or Protein ;
| - 160. APPL EXT FIX-TIB/FIBULA
- [ ] (UMLS (ICD9CM) C0177388) =Therapeutic or Preventive Procedure
|
- 111. Apoptosis Promoter Gene
- [Apoptosis Promoter Genes encode Apoptosis Promoter proteins, which promote the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332323) =Gene or Genome ;
| - 161. Apple Juice
- (UMLS (NCI) C0452454) =Food
|
- 112. Apoptosis Regulation Gene
- [Apoptosis Regulation Genes encode Apoptosis Regulator proteins, which either promote or impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332324) =Gene or Genome ;
| - 162. APPLIC EXT FIX DEV NEC
- [ ] (UMLS (ICD9CM) C0177390) =Therapeutic or Preventive Procedure
|
- 113. Apoptosis Regulator
- [Encoded by Apoptosis Regulation Genes, Apoptosis Regulator proteins either promote or impede the initiation, progress, or rate of apoptosis. ( NCI )] (UMLS (NCI) C1332325) Regulator of Apoptosis =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 163. APPLIC EXT FIX DEV NOS
- [ ] (UMLS (ICD9CM) C0376052) =Therapeutic or Preventive Procedure
|
- 114. Apoptosis Regulator BAK
- [A BCL2 related protein that induces apoptosis. May cause the mitochondrial voltage-dependent anion channel to open and release cytochrome c into the cytoplasm resulting in caspase activation. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C0296517) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 164. APPLIC EXT FIX DEV-FEMUR
- [ ] (UMLS (ICD9CM) C0177386) =Therapeutic or Preventive Procedure
|
- 115. Apoptosis Regulator BCL-W
- [This protein is a member of the BCL-2 protein family. Expression of this protein in cells has been shown to contribute to reduced cell apoptosis under cytotoxic conditions. Studies of the related gene in mice indicated a role in the survival of NGF- and BDNF-dependent neurons. Mutation and knockout studies of the mouse gene demonstrated an essential role in adult spermatogenesis. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C1332395) BCL2 Like 2;
BCL2L2;
BCL2L2 Protein;
BCL2-Like 2;
BCL2-Related 2 Protein;
BCLW;
BCL-W;
KIAA0271;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 165. APPLIC EXT FIX-HUMERUS
- [ ] (UMLS (ICD9CM) C0177383) =Therapeutic or Preventive Procedure
|
- 116. Apoptosis Response Protein
- [Apoptosis Response Protein, encoded by the PAWR gene, is a WT1-interacting protein that itself functions as a transcriptional repressor. It contains a putative leucine zipper domain which interacts with the zinc finger DNA binding domain of WT1. Apoptosis Response Protein is specifically upregulated during apoptosis of prostate cells. (from LocusLink) ( NCI )] (UMLS (NCI) C0529535) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 166. Applicant
- [A person who requests or seeks something such as assistance or employment or admission. ( NCI )] (UMLS (NCI) C0696628) =Human
|
- 117. Apoptosis-Inducing NBK
- [This protein is known to interact with cellular and viral survival-promoting proteins, such as BCL2, BCLXL, Epstein-Barr virus BHRF1, and adenovirus E1B 19-kD in order to enhance programed cell death. Because its activity is suppressed in the presence of survival-promoting proteins, this protein is suggested as a likely target for antiapoptotic proteins. This protein shares a critical BH3 domain with other death-promoting proteins, BAX and BAK. (from RefSeq Summary and OMIM) ( NCI )] (UMLS (NCI) C1332394) BCL2-Interacting Killer;
BIK;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 167. Application
- (UMLS (HL7) C1547755) =Idea or Concept =HL7 Vocabulary Version 2.5;
|
- 118. Apoptotic Cysteine Protease MCH2
- [Caspase-6, encoded by the CASP6 Gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Caspase-6 can be processed by caspases 7, 8 and 10, and functions as a downstream enzyme in the activation cascade of caspases responsible for apoptosis execution. It cleaves poly(ADP-ribose) polymerase in vitro, as well as lamins. Alternative splicing of this gene results in two transcript variants which encode different isoforms. Its overexpression promotes programmed cell death. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0538091) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 168. Application
- [A program that gives a computer instructions that provide the user with tools to accomplish a task. ( NCI )] (UMLS (NCI) C0870325) Computer Application;
=Functional Concept ;
|
- 119. Apoptotic Protease Mch-3
- [Caspase-7, encoded by the CASP7 Gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. The precursor of this caspase can be cleaved by caspase 3 and 10. It has been shown to be activated upon cell death stimuli and induce apoptosis. Alternative splicing of this gene results in 4 transcript variants, which encode 3 distinct isoforms. (From LocusLink and NCI) ( NCI )] (UMLS (NCI) C0537969) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 169. Application Acknowledgement Accept
- [Receiving application successfully processed message. ( HL7V3.0 )] (UMLS (HL7) C1553415) =Idea or Concept =AcknowledgementType;
|
- 120. aporphine
- [Dibenzoquinolines derived in plants from (S)-reticuline (BENZYLISOQUINOLINES). ( MSH )] (UMLS (CSP) C0003606) =Organic Chemical ;
| - 170. Application Acknowledgement Error
- [Receiving application found error in processing message. Sending error response with additional error detail information. ( HL7V3.0 )] (UMLS (HL7) C1553416) =Idea or Concept =AcknowledgementType;
|
- 121. APP ADHESION BARRIER SUB
- (UMLS (ICD9CM) C1135463) Application or administration of adhesion barrier substance =Therapeutic or Preventive Procedure
| - 171. Application Acknowledgement Reject
- [Receiving application failed to process message for reason unrelated to content or format. Original message sender must decide on whether to automatically send message again. ( HL7V3.0 )] (UMLS (HL7) C1553417) =Idea or Concept =AcknowledgementType;
|
- 122. APP EXT FIX DEV-MONOPLAN
- [ ] (UMLS (ICD9CM) C1561937) Application of external fixator device, monoplanar system;
=Therapeutic or Preventive Procedure | - 172. Application change type
- (UMLS (HL7) C1547794) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Migrates to different CPU;
Shut down;
Start up |
- 123. APP EXT FIX DEV-RING SYS
- [ ] (UMLS (ICD9CM) C1561938) Application of external fixator device, ring system;
=Therapeutic or Preventive Procedure | - 173. Application Context
- [A designation or description of the application environment or discipline in which a name is applied or from which it originates. ( NCI )] (UMLS (NCI) C0542559) =Functional Concept ;
|
- 124. APP HYBRID EXT FIX DEV
- [ ] (UMLS (ICD9CM) C1561941) Application of hybrid external fixator device;
=Therapeutic or Preventive Procedure | - 174. Application error
- (UMLS (HL7) C1549777) =Idea or Concept =Query Response Status;
|
- 125. Appeal Reason
- (UMLS (HL7) C1547740) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 175. Application error code
- (UMLS (HL7) C1547905) =Intellectual Product =HL7 Vocabulary Version 2.5;
|
- 126. Appearance
- (UMLS (HL7) C1547010) =Quantitative Concept =Kind of quantity;
| - 176. Application internal error
- [A catchall for internal errors not explicitly covered by other error codes. ( HL7V3.0 )] (UMLS (HL7) C1554179) =Idea or Concept =Message error condition codes;
MessageCondition |
- 127. Appearance
- [The outward or visible aspect of a person or thing. ( NCI )] (UMLS (NCI) C0700364) =Qualitative Concept
| - 177. Application management data message
- (UMLS (HL7) C1548042) =Idea or Concept =Message type;
|
- 128. appendage
- [A natural prolongation or projection from a part of an organism either animal or plant; a part that is joined to something larger. ( NCI )] (UMLS (CSP) C0598782) =Body Part, Organ, or Organ Component ;
| - 178. Application management query message
- (UMLS (HL7) C1548043) =Idea or Concept =Message type;
|
- 129. Appendage of the Uterus
- [The fallopian tubes, ovaries, and supporting ligaments of the uterus. (MeSH) ( NCI )] (UMLS (NCI) C0001575) =Body Part, Organ, or Organ Component ;
| - 179. Application management response message
- (UMLS (HL7) C1548044) =Idea or Concept =Message type;
|
- 130. Appendectomy
- [Surgical removal of the vermiform appendix. ( NCI )] (UMLS (ICD9CM) C0003611) =Therapeutic or Preventive Procedure
| - 180. Application of crown
- (UMLS (ICD9CM) C0003626) =Therapeutic or Preventive Procedure
|
- 131. Appendiceal Carcinoid Neoplasm
- [A well differentiated neuroendocrine neoplasm arising from the wall of the appendix. It is characterized by the presence of neoplastic cells forming round solid nests and occasionally glandular structures. The majority of the cases are asymptomatic, and they are found incidentally in appendectomy specimens. The majority of the tumors are located in the distal end of the appendix and they are enterochromaffin-cell carcinoid tumors producing serotonin. Most cases show morphologic evidence of appendiceal wall and lymphatic vessel invasion by tumor cells. Despite the morphologic evidence of invasion, appendiceal carcinoid tumors only infrequently produce lymph node or distant metastases. ( NCI )] (UMLS (NCI) C0334298) =Neoplastic Process
| - 181. Application of external fixator device
- [ ] (UMLS (ICD9CM) C1561811) =Therapeutic or Preventive Procedure
|
- 132. Appendiceal Colloid Cystadenocarcinoma
- [An adenocarcinoma arising from the appendix, characterized by the presence of mucinous stroma formation and cystic structures. ( NCI )] (UMLS (NCI) C1096639) Appendiceal Colloidal Cystadenocarcinoma;
Appendiceal Mucinous Cystadenocarcinoma;
Appendix Colloid Cystadenocarcinoma;
Appendix Colloidal Cystadenocarcinoma;
Appendix Mucinous Cystadenocarcinoma;
Colloid Cystadenocarcinoma of Appendix;
Colloid Cystadenocarcinoma of the Appendix;
Colloidal Cystadenocarcinoma of Appendix;
Colloidal Cystadenocarcinoma of the Appendix;
Mucinous Cystadenocarcinoma of Appendix;
Mucinous Cystadenocarcinoma of the Appendix =Neoplastic Process ;
| - 182. Application of neck support
- [ ] (UMLS (ICD9CM) C0178034) =Therapeutic or Preventive Procedure
|
- 133. Appendiceal L-Cell Glucagon-Like Peptide Producing Neoplasm
- [A neuroendocrine neoplasm arising from the wall of the appendix, producing glucagon-like peptides. Morphologically, it is characterized by the presence of neoplastic cells forming tubular or trabecular patterns. ( NCI )] (UMLS (NCI) C1332326) Appendiceal L-Cell Glucagon-Like Peptide Producing Tumor =Neoplastic Process ;
| - 183. Application of orthodontic appliance
- [ ] (UMLS (ICD9CM) C0176413) =Therapeutic or Preventive Procedure
|
- 134. Appendiceal Leiomyoma
- [A well-circumscribed benign smooth muscle neoplasm arising from the appendix. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern. ( NCI )] (UMLS (NCI) C1332327) Appendix Leiomyoma;
Leiomyoma of Appendix;
Leiomyoma of the Appendix =Neoplastic Process ;
| - 184. Application of other cast
- (UMLS (ICD9CM) C0687122) =Therapeutic or Preventive Procedure ;
|
- 135. Appendiceal Lymphoma
- [A lymphoma arising from the appendix. The majority of lymphomas affecting the appendix represent disease extension from the intestinal wall; primary lymphomas of the appendix are rare. ( NCI )] (UMLS (NCI) C1332328) Appendix Lymphoma;
Lymphoma of Appendix;
Lymphoma of the Appendix;
Primary Appendix Lymphoma;
=Neoplastic Process ;
| - 185. Application of other wound dressing
- (UMLS (ICD9CM) C0003627) =Therapeutic or Preventive Procedure
|
- 136. Appendiceal Mass
- (UMLS (NCI) C0341353) =Disease or Syndrome
| - 186. Application of plaster jacket
- [ ] (UMLS (ICD9CM) C0178033) =Therapeutic or Preventive Procedure
|
- 137. Appendiceal Mucocele
- (UMLS (NCI) C0026684) =Acquired Abnormality; Disease or Syndrome
| - 187. Application of pressure dressing
- [ ] (UMLS (ICD9CM) C0556856) =Therapeutic or Preventive Procedure
|
- 138. APPENDICEAL OPS NEC
- [ ] (UMLS (ICD9CM) C0176831) =Therapeutic or Preventive Procedure
| - 188. Application of pressure trousers
- [ ] (UMLS (ICD9CM) C0178037) =Therapeutic or Preventive Procedure
|
- 139. Appendicitis
- [Acute inflammation of the APPENDIX. Acute appendicitis is classified as simple, gangrenous, or perforated.(MSH)] (UMLS (ICPC) C0003615) (Appendicitis; APENDIZITISA; Blindtarmsbetaendelse; Appendicitis; UMPILISAKKEEN TULEHDUS/APPENDISIITTI; Appendicite; Appendizitis; (108); appendicitis; Appendicite; BLINDTARMBETENNELSE - k35 - k36 - k37; Apendicite; Apendicitis; BLINDTARMSINFLAMMATION) =Disease or Syndrome
| - 189. APPLICATION OF SPLINT
- (UMLS (ICD9CM) C0204861) =Therapeutic or Preventive Procedure
|
- 140. APPENDICO-VESICOS STATUS
- [ ] (UMLS (ICD9CM) C0695268) =Finding
| - 190. Application record locked
- [The transaction could not be performed at the application storage level, e.g. database locked. ( HL7V3.0 )] (UMLS (HL7) C1554178) =Idea or Concept =Message error condition codes;
MessageCondition |
- 141. APPENDICOSTOMY
- (UMLS (ICD9CM) C0192953) =Therapeutic or Preventive Procedure
| - 191. Application reject
- (UMLS (HL7) C1549778) =Idea or Concept =Query Response Status;
|
- 142. Appendicular Skeleton
- [The part of the skeleton that includes the bones of the upper and lower limbs. ( NCI )] (UMLS (NCI) C0222646) =Body Part, Organ, or Organ Component
| - 192. Application Role
- [Holds the unique identifier of an Application Role (stereotype of class). ( HL7V3.0 )] (UMLS (HL7) C1554129) =Idea or Concept =HL7DefinedRoseProperty;
|
- 143. appendix
- [A small, fingerlike pouch that sticks out from the cecum (the first part of the large intestine near the end of the small intestine). ( NCI )] (UMLS (CSP) C0003617) =Body Part, Organ, or Organ Component
| - 193. ApplicationError
- [Query Error. Application Error. ( HL7V3.0 )] (UMLS (HL7) C1553715) =Idea or Concept =QueryResponse;
|
- 144. appendix
- [Refers to a document serving as an appendix in a collection of documents. ( HL7V3.0 )] (UMLS (HL7) C1552860) =Idea or Concept =HtmlLinkType;
| - 194. ApplicationMediaType
- [Application specific media type. ( HL7V3.0 )] (UMLS (HL7) C1699384) =Classification ;
=MediaType;
=PDF;
MSWORD;
|
- 145. Appendix Carcinoma
- [A malignant epithelial neoplasm arising from the appendix. The vast majority of the cases are adenocarcinomas. ( NCI )] (UMLS (NCI) C0728951) Carcinoma of Appendix;
Carcinoma of the Appendix =Neoplastic Process | - 195. Applicator
- [A device used to apply a liquid or powder to a surface. ( HL7V3.0 )] (UMLS (HL7) C1553476) =Intellectual Product =AdministrationMedicalDevice;
|
- 146. Appendix Goblet Cell Carcinoid Tumor
- [An invasive mixed endocrine-exocrine neoplasm of the appendix characterized by a submucosal growth and the presence of neoplastic signet-ring cells resembling goblet cells of the intestine. It usually has a more aggressive clinical course when compared to conventional carcinoid tumors. ( NCI )] (UMLS (NCI) C0205695) =Neoplastic Process ;
| - 196. Applicatorful
- (UMLS (HL7) C1553205) =Medical Device =AdministrableDrugForm;
|
- 147. APPENDIX INJURY-CLOSED
- [ ] (UMLS (ICD9CM) C0160380) =Injury or Poisoning
| - 197. Applied Genetics
- (UMLS (NCI) C1510933) Genetics, Applied;
=Occupation or Discipline; ;
|
- 148. APPENDIX INJURY-OPEN
- [ ] (UMLS (ICD9CM) C0160388) =Injury or Poisoning
| - 198. Applied Research
- [Research directed toward solving a specific problem (as opposed to Basic Research). ( NCI )] (UMLS (NCI) C0681834) =Research Activity ;
|
- 149. Appendix Mucinous Cystadenoma
- [A cystically dilated epithelial neoplasm arising from the appendix. It is characterized by the presence of a cystic structure that is filled with mucus. ( NCI )] (UMLS (NCI) C1332518) Colloid Appendiceal Cystadenoma;
Colloid Cystadenoma of Appendix;
Colloid Cystadenoma of the Appendix;
Colloidal Cystadenoma of Appendix;
Mucinous Appendiceal Cystadenoma;
Mucinous Appendix Cystadenoma;
Mucinous Cystadenoma of Appendix;
Mucinous Cystadenoma of the Appendix;
=Neoplastic Process | - 199. applies to
- [Entity to which a given value set or concept code applies ( HL7V3.0 )] (UMLS (HL7) C1553879) =Idea or Concept =HL7 Value Set and Coded Concept Property Codes;
|
- 150. Appendix Villous Adenoma
- [An adenoma arising from the appendix. It is characterized by the presence of villous epithelial structures and it is associated with dysplasia. ( NCI )] (UMLS (NCI) C1332329) Villous Adenoma of Appendix;
Villous Adenoma of the Appendix;
=Neoplastic Process ;
| - 200. Apply Externally
- (UMLS (HL7) C0694629) =Functional Concept =drug administration route;
|
home
